Publications by authors named "Howard Sandler"

100Publications

Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review.

JAMA Oncol 2020 Aug 27. Epub 2020 Aug 27.

Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2020.2832DOI Listing
August 2020

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

J Clin Oncol 2020 Aug 9;38(24):2798-2811. Epub 2020 Jun 9.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.00046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430215PMC
August 2020

A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy.

Brachytherapy 2020 Mar - Apr;19(2):216-221. Epub 2020 Jan 19.

Cedars-Sinai Medical Center, Department of Radiation Oncology, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2019.12.001DOI Listing
January 2020

Examinations in Radiation Oncology: Listening, Learning, and Looking Forward Together.

Int J Radiat Oncol Biol Phys 2020 01 21;106(1):29-31. Epub 2019 Oct 21.

John Hopkins School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.10.012DOI Listing
January 2020

Reply to J.B. Aragon-Ching.

J Clin Oncol 2019 09 1;37(25):2297-2298. Epub 2019 Jul 1.

Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01332DOI Listing
September 2019

Responding to Information From Novel Positron Emission Tomography Imaging in Prostate Cancer.

Authors:
Howard M Sandler

Int J Radiat Oncol Biol Phys 2019 06;104(2):263-264

Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.07.189DOI Listing
June 2019

Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changes.

Phys Med Biol 2018 11 7;63(21):215027. Epub 2018 Nov 7.

Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/aae7f1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310012PMC
November 2018

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

J Clin Oncol 2018 Oct 11:JCO1801097. Epub 2018 Oct 11.

Scott C. Morgan, The Ottawa Hospital and University of Ottawa, Ottawa; D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Karen Hoffman, MD Anderson Cancer Center, Houston, TX; Mark K. Buyyounouski, Stanford University, Stanford; Palto Alto VA Health System, Palo Alto, CA; Caroline Patton, American Society for Radiation Oncology, Arlington, VA; Daniel Barocas, Vanderbilt University Medical Center, Nashville, TN; Soren Bentzen, University of Maryland School of Medicine, Baltimore, MD; Michael Chang, Hunter Holmes McGuire VA Medical Center and Virginia Commonwealth University, Richmond, VA; Jason Efstathiou, Massachusetts General Hospital, Boston MA; Patrick Greany, Patient representative, Tallahassee, FL; Per Halvorsen, Lahey Hospital and Medical Center, Burlington, MA; Bridget F. Koontz, Duke University Medical Center, Durham, NC; Colleen Lawton, Medical College of Wisconsin, Milwaukee, WI; C. Marc Leyrer, Wake Forest University, Winston-Salem, NC; Daniel Lin, University of Washington, Seattle, WA; Michael Ray, Radiology Associates of Appleton, ThedaCare Regional Cancer Center, Appleton, WI; and Howard Sandler, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.01097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269129PMC
October 2018

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Ann Intern Med 2018 04;168(8):607-608

Cedar Sinai Medical Center, Los Angeles, California (H.S.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/L17-0734DOI Listing
April 2018

Role of Overall Treatment Time in the Management of Prostate Cancer Patients: How to Manage Unscheduled Treatment Interruptions.

Authors:
Howard M Sandler

Int J Radiat Oncol Biol Phys 2018 03;100(4):841-842

Cedars-Sinai Medical Center, Los Angeles, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.12.278DOI Listing
March 2018

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.

J Urol 2018 04 10;199(4):990-997. Epub 2018 Jan 10.

American Urological Association Education and Research, Inc., Linthicum, Maryland; ASTRO, Arlington, Virginia; Society of Urologic Oncology, Schamburg, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.01.002DOI Listing
April 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.

J Urol 2018 03 15;199(3):683-690. Epub 2017 Dec 15.

American Urological Association Education and Research, Inc., Linthicum, Maryland; ASTRO, Arlington, Virginia; Society of Urologic Oncology, Schamburg, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.11.095DOI Listing
March 2018

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

J Clin Oncol 2017 09 10;35(27):3097-3104. Epub 2017 Aug 10.

Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.9987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652387PMC
September 2017

Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.

Curr Urol Rep 2017 Jul;18(7):55

Department of Radiation Oncology, University of Michigan School of Medicine, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-017-0700-0DOI Listing
July 2017

Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.

BJU Int 2017 11 3;120(5B):E87-E95. Epub 2017 Jun 3.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13903DOI Listing
November 2017

Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

CA Cancer J Clin 2017 05 21;67(3):245-253. Epub 2017 Feb 21.

Chief of Urologic Oncology, Department of Urology, University of Washington, and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375094PMC
May 2017

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

N Engl J Med 2017 02;376(5):417-428

From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444881PMC
February 2017

A two-stage model in a Bayesian framework to estimate a survival endpoint in the presence of confounding by indication.

Stat Methods Med Res 2018 04 1;27(4):1271-1281. Epub 2016 Sep 1.

1 Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0962280216660127DOI Listing
April 2018

Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy.

J Clin Oncol 2016 11;34(32):3829-3833

Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2509DOI Listing
November 2016

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

J Clin Oncol 2016 07 4;34(20):2325-32. Epub 2016 Apr 4.

W. Robert Lee and Bridget F. Koontz, Duke University Medical Center, Durham, NC; James J. Dignam, University of Chicago, Chicago, IL; Mahul B. Amin and Howard M. Sandler, Cedars-Sinai Medical Center; Daniel Low, University of California, Los Angeles, Los Angeles; Samantha A. Seaward, Kaiser Permanente Northern California, Santa Clara, CA; Deborah W. Bruner, Emory University, Atlanta, GA; Gregory P. Swanson, Baylor Scott & White Healthcare Temple Clinic, Temple, TX; Amit B. Shah, York Cancer Center, York; James J. Dignam and Rebecca Paulus, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; David P. D'Souza, London Regional Cancer Program, London, Ontario; Ian S. Dayes, McMaster University, Hamilton, Ontario; Sergio L. Faria, McGill University Health Center, Montreal, Quebec, Canada; Jeff M. Michalski, Washington University School of Medicine, St Louis, MO; William A. Hall, Medical College of Wisconsin, Milwaukee, WI; Paul L. Nguyen, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA; Thomas M. Pisansky, Mayo Clinic, Rochester, MN; and Yuhchyau Chen, University of Rochester, Rochester, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981980PMC
July 2016

Reply by Author.

Authors:
Howard Sandler

J Urol 2015 Nov;194(5):1508-9

View Article

Download full-text PDF

Source
November 2015

Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer.

JAMA Oncol 2015 Aug;1(5):688-9

Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1214DOI Listing
August 2015

Reporting of results in DART01/05 GICOR.

Lancet Oncol 2015 Jun 27;16(6):e258. Epub 2015 May 27.

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70243-3DOI Listing
June 2015

Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.

Eur Urol 2016 Jan 21;69(1):50-7. Epub 2015 May 21.

Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.05.009DOI Listing
January 2016

Radiation for prostate cancer: intensity modulated radiation therapy versus proton beam.

J Urol 2015 Apr 15;193(4):1089-91. Epub 2015 Jan 15.

Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.01.069DOI Listing
April 2015

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

J Clin Oncol 2015 Feb 22;33(4):332-9. Epub 2014 Dec 22.

Thomas M. Pisansky, Mayo Clinic, Rochester, MN; Daniel Hunt and James J. Dignam, Radiation Therapy Oncology Group Statistical Center; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Mahul B. Amin and Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles; Daniel M. Chinn, John Muir Medical Center-Concord Campus, Concord; Seth A. Rosenthal, Sutter Medical Group, Sacramento, CA; Michael J. Seider, Akron City Hospital, Akron, OH; Elizabeth M. Gore, Zablocki Veterans Administration Medical Center-Wood, Milwaukee, WI; Marvin Z. Rotman, Brooklyn Minority-Based Community Clinical Oncology Program, State University of New York Downstate, Brooklyn, NY; William U. Shipley, Massachusetts General Hospital, Boston, MA; James J. Dignam, University of Chicago, Chicago, IL; Alexander G. Balogh, Tom Baker Cancer Centre, Calgary, Alberta; Marie Duclos, McGill University, Montreal, Quebec; Glenn S. Bauman, London Regional Cancer Program, London; and Himanshu R. Lukka, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/12/22/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.0662
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.0662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302214PMC
February 2015

Active surveillance for prostate cancer: the role of the pathologist.

Pathology 2015 Jan;47(1):1-3

1Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand 2Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA 3Department of Oncology and Pathology, Karolinska University Hospital, Solna, Stockholm, Sweden 4Aquesta Pathology and University of Queensland, Brisbane, Qld, Australia 5Trillium Health Partners, Mississauga and McMaster University, Hamilton, ON, Canada 6Department of Pathology, Yale University School of Medicine, New Haven, CT, USA 7Institute for Precision Medicine and the Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell, University and New York-Presbyterian Hospital, New York, NY, USA 8Department of Pathology, Urology and Oncology, Johns Hopkins School of Medicine, Baltimore, MA, USA 9Department of Urology, University of Washington, Seattle, WA, USA 10Department of Surgery, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand 11Division of Urology, Sunnybrook Health Sciences, Centre, University of Toronto, Toronto, ON, Canada 12Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA 13Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA 14Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA 15Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health, Polytechnic University of the Marche Region (Ancona), Ancona, Italy 16University Health Network, University of Toronto, Toronto, Ontario, Canada 17Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH, USA 18Department of Cellular Pathology, The Royal London Hospital, London, UK 19Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA 20Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA 2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000186DOI Listing
January 2015

Stereotactic body radiation therapy: Let's not give up on progress.

Pract Radiat Oncol 2015 May-Jun;5(3):193-196. Epub 2014 Oct 14.

Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2014.09.001DOI Listing
April 2016

US Food and Drug Administration medical device review and approval; myths, misconceptions, realities, and potential policy changes.

Pract Radiat Oncol 2014 Nov-Dec;4(6):472-8. Epub 2014 Apr 18.

Department of Radiation Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2014.02.009DOI Listing
July 2015

Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement.

J Clin Oncol 2014 Dec 3;32(34):3892-8. Epub 2014 Nov 3.

Stephen J. Freedland, Duke University, Durham; Ronald C. Chen, University of North Carolina, Chapel Hill, NC; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Antonio Finelli, Princess Margaret Hospital, University Health Network, Toronto; Colin Wackett, Patient Advocate, Orillia, Ontario, Canada; Susan Slovin, Memorial Sloan Kettering Cancer Center, New York, NY; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; David S. Mendelson, Pinnacle Oncology Hematology, Scottsdale, AZ; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.8525DOI Listing
December 2014

Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary.

J Oncol Pract 2014 Nov;10(6):e415-e417

Duke University, Durham, NC; American Society of Clinical Oncology, Alexandria, VA; and Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001909DOI Listing
November 2014

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.

Arch Pathol Lab Med 2014 Oct 5;138(10):1387-405. Epub 2014 Aug 5.

From the Departments of Pathology and Laboratory Medicine (Drs Amin and Knudsen), Radiation Oncology (Dr Sandler), Urology (Dr Holden), and Biomedical Sciences (Dr Knudsen), Cedars-Sinai Medical Center, Los Angeles, California; the Departments of Urology (Drs Lin and Gore) and Pathology (Dr True), University of Washington, Seattle; Trillium Health Partners, Mississauga, Ontario, Canada, and McMaster University, Hamilton, Ontario, Canada (Dr Srigley); Aquesta Pathology, Toowong, Queensland, Australia, and the University of Queensland, Brisbane (Dr Samaratunga); the Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden (Dr Egevad); the Institute for Precision Medicine and the Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, Ithaca, New York, and New York-Presbyterian Hospital, New York (Dr Rubin); the Departments of Surgery (Dr Nacey) and Pathology and Molecular Medicine (Dr Delahunt), Wellington School of Medicine and Health Sciences, University of Otago, Newtown, Wellington, New Zealand; the James Buchanan Brady Urological Institute (Dr Carter) and the Departments of Pathology (Dr Epstein), Urology (Dr Epstein), and Oncology (Dr Epstein), Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Urology, the Sunnybrook Health Sciences Centre (Dr Klotz) and the University Health Network (Dr Evans), University of Toronto, Toronto, Ontario, Canada; the Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston (Dr Zietman); the Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health, Polytechnic University of the Marche Region, Ancona, Italy (Dr Montironi); the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Humphrey); the Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio (Dr McKenney); the Department of Cell

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0219-SADOI Listing
October 2014

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

J Natl Cancer Inst 2014 Jul 8;106(7). Epub 2014 Jul 8.

Affiliations of authors: Department of Radiation Oncology (RCC, WAS), and Department of Health Policy and Management, Gillings School of Global Public Health (BBR), Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC (RCC, WAS); Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (PC); Mayo Clinic, Rochester, MN (RJV); Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada (HL); Department of Urology (MGS), and Nell Hodgson Woodruff School of Nursing (DW-G), Emory University, Atlanta, GA; Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA (HMS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192044PMC
July 2014

Complications of prostate cancer treatment.

Lancet Oncol 2014 Apr;15(4):e150

Massachusetts General Hospital Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045147012
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(14)70126-3DOI Listing
April 2014

Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose.

Pract Radiat Oncol 2014 Jan-Feb;4(1):27-34. Epub 2013 Mar 29.

Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2013.02.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000550PMC
January 2015